Metformin still remains the first line drug in T2DM. Due to various reasons many patients don't prefer this drug. SGLT-2 RI offers good glycemic effect as well as various nonglycemic benefits. So why not to start this group of drugs instead of metformin in T2DM patients?

could someone please help with literature on type 2 diabetes in England:statisticsdiagnosis and assessmentpreventionpublic health implicationthank you

could someone please help with literature on type 2 diabetes in England:statisticsdiagnosis and assessmentpreventionpublic health implicationthank you